Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar poorbastard2011 (< 20) Submitted: 1/14/2011 7:22:43 AM : Outperform Start Price: $22.63 MYL Score: -7.47

the signs are there...

Featured Broker Partners


Advertisement